Sign In
Buy VYNE
$0.656
-0.0200 (-2.96%)
At Close: Jun 03, 2026
VYNE Stock Price Increases Over 260% Pre-Market: Why It Happened
05:17am, Tuesday, 16'th Feb 2021
The stock price of VYNE Therapeutics (NASDAQ: VYNE) is trading at over 260% pre-market today as of 5:07 AM ET. This is why it happened.
Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More
01:27pm, Saturday, 06'th Feb 2021
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have been taking advantage of secondary offerings recently.
VYNE Stock Price Increases Over 10% Pre-Market: Why It Happened
07:29am, Tuesday, 02'nd Feb 2021
The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) is trading at over 10% pre-market. This is why it happened.
VYNE Therapeutics Announces Closing of $50 Million Registered Direct Offering of Common Stock and Provides Corporate Update
08:00am, Friday, 29'th Jan 2021
BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it has closed its previously announced registered dir
Can Vyne Therapeutics Stock Keep Soaring?
07:57am, Thursday, 28'th Jan 2021
This biotech stock is jumping, but what should investors expect from its new skincare treatments?
VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
07:59am, Tuesday, 26'th Jan 2021
BRIDGEWATER, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), today announced that it has entered into definitive agreements with inst
VYNE Stock: 13 Things to Know About Vyne Therapeutics as Shares Rocket Higher
11:42am, Monday, 25'th Jan 2021
Vyne Therapeutics (VYNE) stock is taking off on Wednesday as investors take an interest in the pharmaceutical company on recent news. The post VYNE Stock: 13 Things to Know About Vyne Therapeutics as
VYNE Stock Price Increases Over 70% Pre-Market: Why It Happened
07:17am, Monday, 25'th Jan 2021
The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) increased by over 70% pre-market today as of 7:06 AM ET today. This is why it happened.
BRIDGEWATER, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the execution of a contract with a major PBM for its novel
VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for FCD105 in Acne
08:00am, Thursday, 17'th Dec 2020
Company on track to initiate the TRILOGY Phase 3 program in 2021 Company on track to initiate the TRILOGY Phase 3 program in 2021
VYNE Therapeutics Added to Nasdaq Biotechnology Index
08:00am, Wednesday, 16'th Dec 2020
BRIDGEWATER, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”), a specialty pharmaceutical company focused on developing and commercializing proprietary therap
VYNE Therapeutics to Present at the 32nd Annual Piper Sandler Healthcare Conference
08:00am, Wednesday, 25'th Nov 2020
BRIDGEWATER, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will partici
VYNE Therapeutics (VYNE) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript
02:36pm, Tuesday, 10'th Nov 2020
VYNE Therapeutics (VYNE) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript
